News
Five of India’s approved insurers are Russian and include Ingosstrakh and Alfastrakhovanie, which were sanctioned by the UK ...
ICON Public Limited Company’s ICLR share price has surged by 5.63%, which has investors questioning if this is right time to sell.
OpenAI picks labor icon Dolores Huerta and other philanthropy advisers as it moves toward for-profit
OpenAI has named labor leader Dolores Huerta and three others to a temporary advisory board that will help guide the ...
The development comes shortly after the European Data Protection Board (EDPB) approved the rollout owing to it meeting legal obligations under the bloc's stringent data protection laws. Last month, ...
The NFL, in collaboration with the NFLPA, through their respective appointed biomechanical experts, coordinated extensive laboratory research to evaluate which helmets best reduce head impact ...
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account. Our weekly podcast on democracy in America. This ...
Microsoft Says It's 'Slowing or Pausing' Some AI Data Center Projects, Including $1B Plan for Ohio Microsoft said it is “slowing or pausing” some of its data center construction, including a $ ...
The Securities and Exchange Commission (SEC) gave the green light for the trading of options tied to ether (ETH) exchange-traded funds (ETFs). On Wednesday, the regulator approved a filing from ...
BUENOS AIRES (Reuters) -Argentina's government expects the International Monetary Fund board will approve a $20 billion loan deal at the end of the week, a government spokesman said on Wednesday ...
Commission Members Joel Rensberger and Tim Davis voted in favor of a motion to recommend approval of Knapp's bill.
The aim is to give approved researchers easy access to data without them having to “navigate different systems or make multiple applications for information for the same project,” the government’s ...
Just last week, the US Food and Drug Administration delayed a decision on full approval of Novavax’s ... told CNN that the FDA is seeking more data on the vaccine, which has been available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results